Apexian Pharmaceuticals Inc. 13D and 13G filings for Opus Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-26 4:05 pm Purchase | 2020-11-06 | 13G | Opus Genetics, Inc. IRD | Apexian Pharmaceuticals Inc. | 779,993 7.136% | 779,993 (New Position) | Filing |